SRF is a nuclear repressor of Smad3-mediated TGF-β signaling

被引:0
|
作者
H-J Lee
C-H Yun
S H Lim
B-C Kim
K G Baik
J-M Kim
W-H Kim
S-J Kim
机构
[1] Laboratory of Cell Regulation and Carcinogenesis,Division of Molecular Therapeutics
[2] National Cancer Institute,Department of Biological Sciences
[3] Korea Research Institute of Bioscience and Biotechnology (KRIBB),Division of Life Sciences
[4] Korea Advanced Institute of Science and Technology,Dr Department of Pathology
[5] Kangwon National University,undefined
[6] Cancer Research Institute,undefined
[7] Seoul National University College of Medicine,undefined
[8] Inha University College of Medicine,undefined
来源
Oncogene | 2007年 / 26卷
关键词
SRF; TGF-; Smad; signaling; transcription; suppression;
D O I
暂无
中图分类号
学科分类号
摘要
Serum response factor (SRF) is a widely expressed transcription factor involved in immediate-early and tissue-specific gene expression, cell proliferation and differentiation. We defined a new role of SRF as a nuclear repressor of the tumor growth factor β1 (TGF-β1) growth-inhibitory signal during cell proliferation. We show that SRF significantly inhibits the TGF-β1/Smad-dependent transcription by associating with Smad3. SRF causes resistance to the TGF-β1 cytostatic response by directly repressing the Smad transcriptional activity and Smad binding to DNA. Furthermore, we demonstrated that overexpression of SRF markedly decreases the level of Smad3 complex binding to the promoters of Smad3 target genes, p15INK4b and p21Cip1. This leads to the inhibition of expression of TGF-β1-responsive genes. SRF therefore acts as a nuclear repressor of Smad3-mediated TGF-β1 signaling.
引用
收藏
页码:173 / 185
页数:12
相关论文
共 50 条
  • [1] SRF is a nuclear repressor of Smad3-mediated TGF-β signaling
    Lee, H-J
    Yun, C-H
    Lim, S. H.
    Kim, B-C
    Baik, K. G.
    Kim, J-M
    Kim, W-H
    Kim, S-J
    ONCOGENE, 2007, 26 (02) : 173 - 185
  • [2] CEACAM5 and CEACAM6 are major target genes for Smad3-mediated TGF-β signaling
    S-U Han
    T-H Kwak
    K H Her
    Y-H Cho
    C Choi
    H-J Lee
    S Hong
    Y S Park
    Y-S Kim
    T-A Kim
    S-J Kim
    Oncogene, 2008, 27 : 675 - 683
  • [3] Hepatitis C viral proteins interact with Smad3 and differentially regulate TGF-β/Smad3-mediated transcriptional activation
    Pei-Lin Cheng
    Meng-Hsiung Chang
    Chi-Hong Chao
    Yan-Hwa Wu Lee
    Oncogene, 2004, 23 : 7821 - 7838
  • [4] Dynamics of TGF-β/Smad signaling
    Zi, Zhike
    Chapnick, Douglas A.
    Liu, Xuedong
    FEBS LETTERS, 2012, 586 (14) : 1921 - 1928
  • [5] TGF-β activated Smad signalling leads to a Smad3-mediated down-regulation of DSPP in an odontoblast cell line
    He, WX
    Niu, ZY
    Zhao, SL
    Jin, WL
    Gao, J
    Smith, AJ
    ARCHIVES OF ORAL BIOLOGY, 2004, 49 (11) : 911 - 918
  • [6] TGF-β signaling by Smad proteins
    Miyazono, K
    CYTOKINE & GROWTH FACTOR REVIEWS, 2000, 11 (1-2) : 15 - 22
  • [7] Transcriptional control by the TGF-β/Smad signaling system
    Massagué, J
    Wotton, D
    EMBO JOURNAL, 2000, 19 (08): : 1745 - 1754
  • [8] Nuclear Export of Smad2 and Smad3 by RanBP3 Facilitates Termination of TGF-β Signaling
    Dai, Fangyan
    Lin, Xia
    Chang, Chenbei
    Feng, Xin-Hua
    DEVELOPMENTAL CELL, 2009, 16 (03) : 345 - 357
  • [9] DHT Selectively Reverses Smad3-Mediated/TGF-β-Induced Responses through Transcriptional Down-Regulation of Smad3 in Prostate Epithelial Cells
    Song, Kyung
    Wang, Hui
    Krebs, Tracy L.
    Wang, Bingcheng
    Kelley, Thomas J.
    Danielpour, David
    MOLECULAR ENDOCRINOLOGY, 2010, 24 (10) : 2019 - 2029
  • [10] Differential regulation of TGF-β signaling through Smad2, Smad3 and Smad4
    Anny Kretschmer
    Kristin Moepert
    Sibylle Dames
    Maria Sternberger
    Joerg Kaufmann
    Anke Klippel
    Oncogene, 2003, 22 : 6748 - 6763